Table 1 Characteristics of the 56 patients and their cancers.

From: A role for the immune system in advanced laryngeal cancer

Characteristic

Category

N = 56 (100)

Age, Median (IQR)

 

63 (55–71)

Sex, n (%)

Male

48 (86)

 

Female

8 (14)

BMI, Median (IQR), Kg/m2

 

25 (23.5–27.4)

Alcohol, n. (%)

Yes

4 (7)

No

52 (93)

Smoker, n. (%)

Yes

26 (46)

No

30 (54)

Side, n. (%)

Right

16 (28)

Left

21 (38)

Median

11 (20)

Bilateral

8 (14)

Disease site, n. (%)

Glottic

21 (37)

Hypoglottic

2 (4)

Transglottic

7 (13)

Sovraglottic

26 (46)

pT, n. (%)

1

2 (4)

2

5 (9)

3

23 (41)

4

26 (46)

pN, n. (%)

0

26 (47)

1

7 (13)

2a

2 (4)

2b

10 (18)

2c

7 (13)

3

3 (5)

Leukocytes, Median (IQR)

 

8.15 (6.5–9.8)

Neutrophils, Median (IQR)

 

5 (4.1–6.3)

Eosinophils, Median (IQR)

 

0.17 (0.08–0.26)

Basophils, Median (IQR)

 

0.03 (0.01–0.04)

Lymphocytes, Median (IQR)

 

1.88 (1.5–2.4)

Monocytes, Median (IQR)

 

0.7 (0.5–0.8)

Neutrophil-to-lymphocyte ratio (relative count) Median (IQR) ABBREVIATIONS MUST BE DEFINED

 

2.33 (1.97–3.17)

Neutrophil-to-lymphocyte ratio (absolute count) Median (IQR)

 

2.43 (2.02–3.43)

Treatment, n (%)

Surgery + RT + CT

16 (29)

Surgery + RT

30 (53)

Surgery + CT

1 (2)

Surgery

8 (14)

RT

1 (2)

  1. RT radiotherapy; CT chemiotherapy.